Mutual Advisors LLC Acquires 867 Shares of Kenvue Inc. (NYSE:KVUE)

Mutual Advisors LLC grew its holdings in Kenvue Inc. (NYSE:KVUE) by 5.7% in the first quarter, HoldingsChannel reports. The fund owned 15,994 shares of the company’s stock after buying an additional 867 shares during the period. Mutual Advisors LLC’s holdings in Kenvue were worth $368,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the business. Price T Rowe Associates Inc. MD lifted its position in Kenvue by 3.5% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 245,885,918 shares of the company’s stock worth $5,249,665,000 after purchasing an additional 8,211,748 shares during the period. Vanguard Group Inc. lifted its position in Kenvue by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 218,543,705 shares of the company’s stock worth $4,665,908,000 after purchasing an additional 1,636,741 shares during the period. Massachusetts Financial Services Co. MA lifted its position in Kenvue by 12.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 97,661,344 shares of the company’s stock worth $2,085,070,000 after purchasing an additional 10,682,003 shares during the period. Geode Capital Management LLC raised its position in Kenvue by 3.1% during the fourth quarter. Geode Capital Management LLC now owns 46,068,931 shares of the company’s stock valued at $980,989,000 after purchasing an additional 1,391,854 shares in the last quarter. Finally, Franklin Resources Inc. raised its position in Kenvue by 61.5% during the fourth quarter. Franklin Resources Inc. now owns 42,719,377 shares of the company’s stock valued at $912,059,000 after purchasing an additional 16,269,721 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on KVUE shares. Citigroup restated a “neutral” rating on shares of Kenvue in a research report on Friday, June 13th. Redburn Atlantic assumed coverage on shares of Kenvue in a research report on Thursday, April 10th. They set a “neutral” rating and a $23.50 price objective for the company. Evercore ISI assumed coverage on Kenvue in a research note on Monday, March 24th. They set an “in-line” rating and a $25.00 target price for the company. UBS Group boosted their target price on Kenvue from $24.00 to $25.00 and gave the stock a “neutral” rating in a research note on Friday, May 9th. Finally, Barclays boosted their target price on Kenvue from $22.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Monday, May 12th. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $25.33.

Kenvue Stock Performance

Kenvue stock opened at $20.71 on Wednesday. The business has a 50 day moving average of $22.57 and a 200-day moving average of $22.32. Kenvue Inc. has a 1 year low of $17.67 and a 1 year high of $25.17. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.86 and a quick ratio of 0.60. The company has a market capitalization of $39.74 billion, a P/E ratio of 37.66, a P/E/G ratio of 3.25 and a beta of 0.83.

Kenvue (NYSE:KVUE) last released its earnings results on Thursday, May 8th. The company reported $0.24 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.01. The business had revenue of $3.74 billion during the quarter, compared to the consensus estimate of $3.69 billion. Kenvue had a net margin of 6.90% and a return on equity of 20.87%. The company’s revenue for the quarter was down 3.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.28 EPS. On average, equities research analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th were issued a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.96%. The ex-dividend date was Wednesday, May 14th. Kenvue’s payout ratio is 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.